The Use of Vibrational Methods of Influencing the Lungs to Restore Their Functional State

August 18, 2023 updated by: Aleksandr Eremenko, Petrovsky National Research Centre of Surgery

The Use of Vibrational Methods of Influencing the Lungs to Restore Their Functional State After Major Reconstructive Cardiac Surgery

There will be formed of groups for application of vibration methods on the lungs: the method of vibroacoustic lung massage using the "BARK VibroLUNG" device; the method of oscillating PEP therapy using Acapella DH Green; the method of hardware stimulation of cough with a mechanical insufflator-aspirator Comfort Cough Plus (Comfortable cough Plus). As a control group, classical manual chest massage with percussion and verbal stimulation of cough against the background of chest compressions with a total duration of 15 minutes will be used

Study Overview

Status

Completed

Conditions

Detailed Description

The patient signs an informed consent to participate in the study after 10-12 hours tracheal extubation and transfer of the patient to spontaneous respiration. The application of one or another method of influence is carried out by the method of random sampling (the envelope method). Next, a session is conducted using one of the methods of vibrational respiratory therapy. We are exploring the gas composition of arterial blood is examined, spirometry, and the respiratory rate is measured after 20 minutes of the procedure. Further, respiratory therapy sessions are repeated 3 times a day for three days

Study Type

Interventional

Enrollment (Actual)

240

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Moscow, Russian Federation
        • Petrovsky Research National Center of Surgery

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Age from 18 years to 80 years inclusive.
  2. Performed cardiac surgery in IC conditions.
  3. The patient's consent to participate in this study.

Exclusion Criteria:

  1. Lack of productive contact with the patient
  2. Any disorder in the central nervous system in the perioperative period (acute cerebrovascular accident, coma, posthypoxic encephalopathy), being on a ventilator.
  3. Unstable hemodynamics or hemodynamically significant rhythm disturbances
  4. Shocks of various etiologies
  5. Inability to provide respiratory protection, high risk of aspiration
  6. Refusal of the patient to participate in this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: the first group: the method of vibroacoustic lung massage using the "BARK VibroLUNG" device
dynamics blood saturation by pulse oximeter,minute inspiratory lung volume befor/after research
Positive dynamics during CT or X-ray examinations in the form of reduction of hypoventilation zones, straightening of lung tissue
Experimental: the second group:the method of oscillating REР therapy using Acapella DH Green
dynamics blood saturation by pulse oximeter,minute inspiratory lung volume befor/after research
Positive dynamics during CT or X-ray examinations in the form of reduction of hypoventilation zones, straightening of lung tissue
Experimental: the third group:the method of hardware stimulation of cough (Comfortable cough Plus)
dynamics blood saturation by pulse oximeter,minute inspiratory lung volume befor/after research
Positive dynamics during CT or X-ray examinations in the form of reduction of hypoventilation zones, straightening of lung tissue
Experimental: the fourth group:classical manual chest massage with percussion
dynamics blood saturation by pulse oximeter,minute inspiratory lung volume befor/after research
Positive dynamics during CT or X-ray examinations in the form of reduction of hypoventilation zones, straightening of lung tissue

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the minute inspiratory lung volume
Time Frame: hospitalisation period, an average of 1 week
Comparison of minute inspiratory lung volume befor/after research using a spirometer
hospitalisation period, an average of 1 week
arterial blood oxygenation level
Time Frame: hospitalisation period, an average of 1 day
Comparison arterial blood oxygenation level before/after researchin the study of arterial blood
hospitalisation period, an average of 1 day
SpO2 more than 92%
Time Frame: hospitalisation period, an average of 3 day
Comparison of SpO2 by pulse oximeter befor/after research (SpO2>92%)
hospitalisation period, an average of 3 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the number of complications
Time Frame: hospitalisation period, an average of 1 week
Comparison of the number of complications befor/after research
hospitalisation period, an average of 1 week
assessment of the duration of hospital stay
Time Frame: hospitalisation period, an average of 1 week
Comparison of assessment of the duration of hospital stay befor/after research
hospitalisation period, an average of 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Alexander А Eremenko, prof, Head of the Intensive Care Unit
  • Principal Investigator: Darya Ryabova, anesthesiologist-resuscitator

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 18, 2022

Primary Completion (Actual)

May 14, 2023

Study Completion (Actual)

May 14, 2023

Study Registration Dates

First Submitted

November 17, 2021

First Submitted That Met QC Criteria

December 2, 2021

First Posted (Actual)

December 16, 2021

Study Record Updates

Last Update Posted (Actual)

August 23, 2023

Last Update Submitted That Met QC Criteria

August 18, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 09052021

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Failure

Clinical Trials on prevention of respiratory failure

Subscribe